{"id":"W1506450640","doi":"10.1016/s2213-2600(15)00197-6","title":"Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; University of Calgary","funders":"National Institutes of Health; MedImmune; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Asthma; Placebo; Population; Exacerbation; Clinical endpoint; Formoterol; Randomized controlled trial; Adverse effect; Intention-to-treat analysis; Placebo-controlled study; Clinical trial; Physical therapy; Internal medicine; Pediatrics; Double blind; Budesonide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002500234,0.002531197,0.004110937,0.000450987,0.0007108882,0.001542823,0.00120906,0.002972142,0.00655635],"category_scores_gemma":[0.002413832,0.0009228751,0.003466343,0.0004616675,0.00154171,0.001518767,0.0004378045,0.004415453,0.001265726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00100615,"about_ca_system_score_gemma":0.001139391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001277278,"about_ca_topic_score_gemma":0.002393765,"domain_scores_codex":[0.9990619,0.0004237626,0.00007103188,0.0002107676,0.00007602461,0.000156586],"domain_scores_gemma":[0.9987335,0.0004248646,0.0003064202,0.0001034813,0.00008977108,0.000341988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9894359,0.001534123,0.0003622033,0.000652073,0.0008721628,0.00002978683,0.00003611177,0.0001338855,0.001677134,0.00004008875,0.0004245382,0.004802029],"study_design_scores_gemma":[0.9750152,0.02242549,0.001336568,0.00002769292,0.0005404918,0.00002680351,0.00001499142,0.0001416546,0.0001531861,0.00004600447,0.0002589246,0.00001300721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800462,0.01135901,0.0006049174,0.001057386,0.001000541,0.002600771,0.001381995,0.0001381422,0.001811087],"genre_scores_gemma":[0.9860005,0.004229518,0.001049402,0.00127658,0.0007310876,0.002646487,0.001163461,0.00003080222,0.002872264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00655635,"threshold_uncertainty_score":0.0219332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04495044110274853,"score_gpt":0.3217763188468193,"score_spread":0.2768258777440708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}